Fetroja® (cefiderocol) | Downloadable Resources
INDICATIONS AND IMPORTANT SAFETY INFORMATION. Indications and usage. Fetroja ® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated …
Fetroja® (cefiderocol) | Official HCP Site
INDICATIONS AND IMPORTANT SAFETY INFORMATION. Indications and usage. Fetroja ® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated …
Fetroja® (cefiderocol) | How Fetroja works
INDICATIONS AND IMPORTANT SAFETY INFORMATION. Indications and usage. Fetroja ® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated …
Fetroja® (cefiderocol) | Administering Fetroja
Fetroja is primarily excreted by the kidney 1; Three-hour infusion time regardless of creatinine clearance 1; The recommended duration of treatment with Fetroja is 7 to 14 days 1; The …
Fetroja® (cefiderocol) | The Battle for Iron
INDICATIONS AND IMPORTANT SAFETY INFORMATION. Indications and usage. Fetroja ® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated …
Fetroja® (cefiderocol) | Antimicrobial Activity
INDICATIONS AND IMPORTANT SAFETY INFORMATION. Indications and usage. Fetroja ® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated …
Fetroja® (cefiderocol) | Structure
INDICATIONS AND IMPORTANT SAFETY INFORMATION. Indications and usage. Fetroja ® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated …
Fetroja® (cefiderocol) | Bacterial Threats
INDICATIONS AND IMPORTANT SAFETY INFORMATION. Indications and usage. Fetroja ® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated …
Fetroja® (cefiderocol) | Carbapenem Resistance
β-lactamase hydrolysis inactivates drug. In Acinetobacter baumannii, primary mechanism is OXA carbapenemase production (such as OXA-23) and all isolates contain chromosomally encoded …
Fetroja® (cefiderocol) | Real-World Evidence | PROVE
In the overall population (N=244), 2% (n=5) of patients experienced 6 adverse drug reactions (1 diarrhea [suspected Clostridioides difficile but never confirmed], 1 diarrhea that could have …